Results 121 to 130 of about 38,310 (188)

Innovative Insurance to Improve US Patient Access to Cell and Gene Therapy. [PDF]

Milbank Q
Conti RM, Demartino P, Gruber J, Lo AW, Sun Y, Wu J.   +5 more
europepmc   +1 more source

On automatic bias reduction for extreme expectile estimation. [PDF]

Stat Comput, 2022
Girard S, Stupfler G, Usseglio-Carleve A.   +2 more
europepmc   +1 more source

Banding Together to Lower the Cost of Health Care? An Empirical study of the Peak Health Alliance in Colorado. [PDF]

J Risk Insur
Meiselbach MK, Eisenberg MD.
europepmc   +1 more source

Tight Bounds for Joint Distribution Functions of Order Statistics Under <i>k</i>-Independence. [PDF]

Entropy (Basel)
Okolewski A, Blazejczyk-Okolewska B.
europepmc   +1 more source

Reconciled multiplicative relational two-stage network data envelopment analysis. [PDF]

MethodsX
Erturan MB.
europepmc   +1 more source

Enhancing translational research impact through collaborative process innovation. [PDF]

J Clin Transl Sci
Palm ME, Phares S, Hirsch G.
europepmc   +1 more source

Changes to ACA Individual Insurance Markets After States Leave Healthcare.gov 2016-2023. [PDF]

Inquiry
Anderson DM, Beniwal S, Kanimian S.
europepmc   +1 more source

Ensuring patient access to gene therapies for rare diseases: Navigating reimbursement and coverage challenges. [PDF]

Mol Ther Methods Clin Dev
Berry D, Hickey C, Kahlman L, Long J, Markus C, McCombs CK.   +5 more
europepmc   +1 more source

Improving the Performance of Risk Adjustment Systems: Constrained Regressions, Reinsurance, and Variable Selection. [PDF]

Am J Health Econ, 2021
McGuire TG, Zink AL, Rose S.
europepmc   +1 more source

The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation study. [PDF]

J Manag Care Spec Pharm
Aguilar AS, Engel T, Furnback W, Dieguez G, Campbell DJ, Diner B, Sullivan SD, Dorling W.   +7 more
europepmc   +1 more source